SLSmaranda Leu-Semenescu

Smaranda Leu-Semenescu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Smaranda Leu-Semenescu has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Isabelle Arnulf

    Sleep Clinic, Pitie-Salpetriere Hospital, DMU APPROCHES, Assistance Publique-Hôpitaux de Paris- Sorbonne Université, Paris, France; Paris Brain Institute (ICM), DreamTeam, Paris, France

    11 shared publications
  • Pauline Dodet

    Sleep Clinic, Pitié-Salpêtrière University Hospital, AP-HPSorbonne, Paris, France

    10 shared publications
  • Ana Gales

    Sleep Clinic, Pitié-Salpêtrière University Hospital, AP-HPSorbonne, Paris, France

    7 shared publications
  • Jean-Baptiste Maranci

    Sleep Clinic, Pitié-Salpêtrière University Hospital, AP-HPSorbonne, Paris, France

    6 shared publications
  • Isabelle Arnulf

    Sleep Clinic, Pitié-Salpêtrière University Hospital, AP-HPSorbonne, Paris, France

    4 shared publications
  • Elisabeth Groos

    Sleep Clinic, Pitie-Salpetriere Hospital, APHP-Sorbonne , Paris , France

    3 shared publications

Latest Publications

  • Open Access

    Correction to: Clinical and polysomnographic changes in idiopathic hypersomnia ten years after the diagnosis

    by Smaranda Leu-Semenescu, Jean-Baptiste Maranci, Benjamin Dudoignon, Ana Gales, Magali Sallansonnet- Froment, Pauline Dodet, Isabelle Arnulf

  • Clinical and polysomnographic changes in idiopathic hypersomnia ten years after the diagnosis

    by Smaranda Leu-Semenescu, Jean-Baptiste Maranci, Benjamin Dudoignon, Ana Gales, Magali Sallansonnet- Froment, Pauline Dodet, Isabelle Arnulf

    Purpose Idiopathic hypersomnia (IH) is characterized by excessive daytime sleepiness and an excessive need for sleep. It is unknown whether the disorder is stable or improves with time. Our goal was to characterize the evolution of clinical and sleep patterns (including measures of excessive sleep need) in patients with IH over a ten-year period. Methods A standardized questionnaire focusing on the progression of clinical symptoms was sent to all patients with IH. At the time of diagnosis, all patients underwent overnight polysomnography and a multiple sleep latency test (MSLT), followed by 18-h bed rest sleep monitoring. This procedure was repeated with a subset of volunteers ten years later. Results A total of 123 participants with IH (83.7% female, mean age 29 ± 11 years) were observed for an average of 9.8 ± 4.3 years and 44 of them had 48-h sleep recordings at baseline and follow-up. The percentage of patients with sleep attacks decreased from 58 to 28% and those with sleep drunkenness decreased from 93 to 79%. Nighttime sleep (restricted/unrestricted) decreased by 1- 3 h, and naps by 0.7 h. Despite these changes, 84/123 patients (68.3%) continued to experience hypersomnolence, while 39/123 patients showed improvement. No baseline clinical characteristics could predict long-term improvement. Ten years after their initial diagnosis, only 26/44 (59%) of the participants continued to meet the polysomnographic criteria for central hypersomnia. Conclusion Sleep time decreases after ten years of IH evolution, suggesting a decrease in sleep pressure with aging. However, persistent somnolence complaints indicate a stable clinical burden. Brief summary Current Knowledge/Study Rationale: Idiopathic hypersomnia (IH) is a rare sleep disorder characterized by an excessive need for sleep and severe daytime sleepiness. Few studies have examined its long-term progression, and none have objectively assessed changes in sleep excess using bed rest recordings. This study re-evaluated objective sleep need in patients with IH ten years after the diagnosis using the same extended bed rest protocol. While sleep time decreases, excessive daytime sleepiness and sleep drunkenness persist. At follow-up, 41% of patients no longer met polysomnographic criteria for IH, yet most continued stimulant therapy. Complete remission remained uncommon (4%). Study Impact: These findings confirm the chronic clinical burden of IH and may prompt reconsideration of current diagnostic criteria, particularly for older patients.

  • Familial and sporadic non-rapid eye movement parasomnia in adults: clinical and sleep differences

    by Angelo Battiato, Pauline Dodet, Charlotte Chaumereuil, Jean-Baptiste Maranci, Smaranda Leu-Semenescu, Ana-Zenovia Gales, Alexander J Groffen, Isabelle Arnulf

    Study Objectives: The heritable trait of non-rapid eye movement (NREM) parasomnias is well known, but differences between sporadic and familial phenotypes have not been studied. The aim of our study was to evaluate, in a clinical series of adults with NREM parasomnias, clinical and sleep differences between familial versus sporadic forms, and between childhood versus adolescent versus adult-onset forms. Methods: We prospectively collected clinical features, family history, questionnaires (Epworth Sleepiness Score and Paris Arousal Disorders Severity Scale (PADSS)), and video-polysomnography measures from patients with NREM parasomnias confirmed by video-polysomnography, admitted over a 12-year period. Familial NREM parasomnia was defined as having at least one relative of the index case with NREM parasomnia. Results: Of the 625 consecutive adults with NREM parasomnias, 50% had a family history of NREM parasomnia (most commonly parents, followed by siblings, then children). Compared to those with sporadic NREM parasomnias, participants with familial NREM parasomnias had an earlier age of onset and greater severity of NREM parasomnias (according to the PADSS). They were more likely to report sleepwalking, sleep terrors, and a combination of parasomniac manifestations (but no more confusional arousals or sleep-related eating disorders), and were less likely to report sexsomnia. In contrast, monthly episode frequency, sleepiness score, sleep structure, and EEG and behavioral markers of NREM parasomnias did not differ between groups. Conclusions: Familial NREM parasomnias have a typical phenotype with an earlier age of onset and a more severe clinical course. This phenotyping may guide medical care and future genetic studies.


  • Open Access

    Early brain iron changes in Parkinson's disease and isolated rapid eye movement sleep behaviour disorder: a four-year longitudinal multimodal quantitative MRI study

    by Rahul Gaurav, François-Xavier Lejeune, Mathieu D Santin, Romain Valabrègue, Jean-Baptiste Pérot, Nadya Pyatigorskaya, Graziella Mangone, Smaranda Leu-Semenescu, Nicolas Villain, Marie-Odile Habert, et al.

    Parkinson's disease demonstrates increased iron concentration in the substantia nigra (SN). The progression of iron and its interaction with neuromelanin content and dopaminergic dysregulation from prodromal to early-stage Parkinson's disease remain poorly understood. Using quantitative susceptibility mapping (QSM) and R2* relaxation rate, we investigated brain iron changes in patients with isolated rapid eye movement (REM) sleep behaviour disorder and early-stage Parkinson's disease. Subjects were scanned longitudinally at 3.0 Tesla MRI. QSM and R2* values were calculated in the entire SN and its anterior and posterior dorsal and ventral subdivisions. Baseline and longitudinal group differences were tested using analysis of variance of multiple linear regression models controlling for age and sex and linear mixed-effects modelling respectively. We included 44/36/28 healthy volunteers (HVs), 49/20/11 isolated REM sleep behaviour disorder, 127/88/50 Parkinson's disease at first/second/third visit respectively, separated by a 2-year interval. At baseline, there was a significant increase in QSM and R2* values in Parkinson's disease versus HVs in the posteroventral SN only (QSM: +17.6%%; R2*: +7.1%), which did not reach significance in isolated REM sleep behaviour disorder (QSM: +6.9%, R2*: +3.3%). Longitudinally, only posteroventral SN values demonstrated significant effects for Group and Visit using QSM and R2*. Further, the Group-by-Visit interaction was significant only for QSM. The posteroventral SN iron increased with disease duration and was inversely correlated with the changes in nigral neuromelanin content and striatal DaT levels in Parkinson's disease. The posteroventral nigral iron increased with the progression of the disease as well as dopaminergic denervation in Parkinson's disease. QSM was a stronger quantitative longitudinal marker than R2* in detecting regional nigral iron abnormalities as the disease progressed.


  • Open Access

    Talking to sleepwalkers? Response to communication efforts in disorders of arousals

    by Yannis Idir, Régis Lopez, Amélie Barbier, Sony Saint-Auret, Emmanuel Morain, Raphaël Vollhardt, Inès Ben Haj Kacem, Arthur Le Coz, Ana Gales, Pauline Dodet, et al.

    Study Objectives: Disorders of arousal (DoA) are diagnosed on the basis of clinical criteria, including inappropriate or absent responsiveness to communication attempts. Surprisingly, the ability of patients to interact with others during DoA episodes has not been systematically investigated. To address this gap, we conducted three studies. Methods: First, we used a retrospective questionnaire to assess verbal responsiveness during episodes in 61 adult patients with DoA (Study 1). Second, we used auditory stimulation during polysomnographically verified N3 sleep to trigger DoA episodes in 14 patients. We then asked questions to test the possibility of verbal interactions during the episodes (Study 2). Third, we assessed the presence and quality of conversations with a bed partner in 364 home video-recorded episodes from 19 patients (Study 3). Results: In Study 1, most patients (81%) reported occasional conversations during parasomnia episodes. Patients’ ongoing mental content influenced both their responses to questions during episodes and their perception of the outside world (including their surroundings and the identity of their interlocutor ). In Study 2, auditory stimulation had a limited effect in inducing episodes (7/157 trials). One patient indirectly responded to our verbal prompts in a DoA episode. In Study 3, we found 37 video instances of discussion between patients and their partner. Conclusions: Overall, our findings suggest that DoA episodes are not a uniform state but may instead encompass varying states of consciousness, characterized by different levels of responsiveness and a complex interplay between internal and external information processing. These results highlight the limitations of current diagnostic criteria for DoA.


  • “I know when to stop”: sentinels and counterstrategies against drowsy driving in narcolepsy and idiopathic hypersomnia

    by Elsa Beguin, Jean Baptiste Maranci, Smaranda Leu-Semenescu, Pauline Dodet, Ana Gales, Delphine Oudiette, Thomas Andrillon, Isabelle Arnulf

    Study Objectives: To collect prodromal symptoms experienced by participants with narcolepsy and idiopathic hypersomnia (considered “hypersomnolence experts”) prior to drowsy driving and counterstrategies used to maintain alertness. Methods: Systematic, face-to-face interview (using a semi-structured questionnaire), including clinical measures, frequency of car accidents/near misses, and symptoms experienced before impending drowsy driving episodes and counterstrategies. Results: Among 61 participants (32 with narcolepsy, 29 with idiopathic hypersomnia; 56 drivers), 61% of drivers had at least one lifetime accident/near miss. They had a higher sleepiness score (14 ± 4 vs. 11 ± 5, p < .04) than those without an accident/near miss, but no other differences in demographics, driving experience, medical conditions, symptoms, sleep tests, and treatment. All but three participants experienced prodromal symptoms of drowsy driving, which included postural and motor changes (86.9%: axial hypotonia—e.g. eyelid droop, stereotyped movements), cognitive impairment (53.3%: automatic steering, difficulty concentrating/shifting, dissociation, mind wandering, dreaming), sensory (65%: paresthesia, pain, stiffness, heaviness, blunted perceptions such as a flat dashboard with loss of 3D, illusions and hallucinations), and autonomic symptoms (10%, altered heart/breath rate, penile erection). Counterstrategies included self-stimulation from external sources (pain, cold air, music, drinks, and driving with bare feet), motor changes (upright posture and movements), and surprise (sudden braking). Conclusions: Drowsy driving symptoms can result from “local” NREM, entry in N1 sleep, and hybrid wake/REM sleep states. These rich qualitative insights from participants with narcolepsy and idiopathic hypersomnia, as well as sophisticated counterstrategies, can be gathered to reduce the crash risk in this population, but also in inexperienced healthy drivers.


  • Circadian Motor Improvement in MS and Core Body Temperature Dipping

    by Milan Nigam, Alain Créange, Smaranda Leu-Semenescu

    This case report describes a man with multiple sclerosis and insomnia who noticed improved motor function during nocturnal awakenings compared with daytime.

  • Latency to N3 interruption in arousal disorders

    by Carlos Perretti, Ana Gales, Smaranda Leu-Semenescu, Pauline Dodet, Clara Bianquis, Elisabeth Groos, Monica Puligheddu, Jean-Baptiste Maranci, Isabelle Arnulf

    Study Objectives: To help expert witnesses in criminal cases using the “sleepwalking defense,” we studied the time of first and last interruptions from stage N3 in patients with arousal disorders, including sexsomnia, as well as their determinants. Methods: The epochs of lights off, sleep onset, first N3 interruption (with and without behaviors), and last N3 interruption were determined by videopolysomnography on two consecutive nights in 163 adults with disorders of arousal, including 46 with and 117 without sexsomnia. Results: The first N3 interruption (independently of concomitant behavior) occurred as early as 8 minutes after sleep onset and within 100 minutes of falling asleep in 95% of cases. The first motor arousal from N3 occurred as early as 25 minutes after lights off time, a timing more variable between participants (between 30 and 60 minutes after lights off time in 25% of participants and within 60 minutes of falling asleep in 50%). These latencies did not differ between the groups with and without sexsomnia. No correlation was found between these latencies and the young age, sex, or clinical severity. The latency of motor arousals was shorter when they were associated with a fast-wave EEG profile and were not preceded by another type of N3 arousal. Conclusions: The first motor arousal may occur early in the night in patients with arousal disorders, with or without sexsomnia, suggesting that abnormal behaviors occurring as early as 25 minutes after lights off time in clinical and criminal cases can be a parasomnia manifestation.


  • Do the EEG and behavioral criteria of NREM arousal disorders apply to sexsomnia?

    by Jessica Rossi, Ana Gales, Valérie Attali, Smaranda Leu-Semenescu, Pauline Dodet, Elisabeth Groos, Isabelle Arnulf

    Study Objectives: To establish whether the recent EEG and behavioral criteria of arousal disorders apply to sexsomnia. Methods: EEG and behavioral markers upon N3 sleep interruptions in videopolysomnography were retrospectively compared in 24 participants with sexsomnia, 41 participants with arousals disorders, and 40 healthy controls. The specificity and sensitivity of previously suggested EEG and behavioral cutoffs for supporting arousal disorders diagnosis were measured in the sexsomnia vs. control groups. Results: Participants with sexsomnia and arousals disorders showed a higher N3 fragmentation index, slow/mixed N3 arousal index, and number of eye openings during N3 interruptions than healthy controls. Ten (41.7%) participants with sexsomnia (vs. one sleepwalker and no control) displayed an apparently sexual behavior (masturbation, sexual vocalization, pelvic thrusting, and hand within the pajama) during N3 arousal. An N3 sleep fragmentation index ≥6.8/h of N3 sleep and two or more N3 arousals associated with eye opening was 95% specific but poorly (46% and 42%) sensitive for diagnosing sexsomnia. An index of slow/mixed N3 arousals ≥2.5/h of N3 sleep was 73% specific and 67% sensitive. An N3 arousal with trunk raising, sitting, speaking, showing an expression of fear/surprise, shouting, or exhibiting sexual behavior was 100% specific for a diagnosis of sexsomnia. Conclusions: In patients with sexsomnia, videopolysomnography based markers of arousal disorders are intermediate between healthy individuals and patients with other arousal disorders, supporting the concept of sexsomnia as a specialized, but less neurophysiologically severe, NREM parasomnia. Previously validated criteria for arousal disorders partially fit in patients with sexsomnia.


  • Hypersomnia and narcolepsy in 42 adult patients with craniopharyngioma

    by Pauline Dodet, Camille Noiray, Smaranda Leu-Semenescu, Etienne Lefevre, Milan Nigam, Pauline Faucher, Jean-Baptiste Maranci, Christel Jublanc, Christine Poitou, Isabelle Arnulf

    To evaluate sleep, sleepiness and excessive need for sleep in patients with craniopharyngioma (a suprasellar tumor which can affect sleep-wake systems). A retrospective study of all adult craniopharyngioma patients referred to the sleep clinic, who received a sleep interview, nocturnal polysomnography, multiple sleep latency tests (MSLT) and 18-hour bed rest polysomnography. Their sleep measurements were compared with those of age- and sex-matched healthy controls. Of 54 patients screened with craniopharyngioma, 42 were analyzed, 80% of whom complained of excessive daytime sleepiness. Sleep testing revealed that 6 (14.3%) of them had secondary narcolepsy (including one with cataplexy), and 11 (26.2%) had central hypersomnia associated with a medical disorder. Compared with controls, patients were more frequently obese, had a shorter mean sleep latency on MSLT and slept longer on the first night. There was a non-significant trend for patients with (vs. without) narcolepsy and hypersomnia to be younger, to have a higher body mass index, to be more likely to have received radiation therapy and to have more severe damage to the hypothalamus after surgery. Treatment with stimulants (modafinil, pitolisant and methylphenidate) was beneficial in 9/10 patients. Nearly half of the patients with craniopharyngioma and sleep disorders have a central disorder of hypersomnolence (narcolepsy and hypersomnia), which should be investigated and lead to considerations beyond sleep apnea syndrome in these obese patients.